Inovio Shares Up This Week On New Vaccine Trials Targeting Virus Outbreaks
January 31, 2016 at 11:06 AM EST
Even though the study won’t begin a phase 1 trial for the Zika virus until Q4 2016, shares of Inovio have continued to climb last week regardless. Shares of Inovio have gained approximately 32% last week.
